TY - JOUR
AU - Paldánius, Päivi Maria
TI - Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study.
JF - The Lancet
DO - 10.1016/S0140-6736(13)60995-2
DA - 2013-09-16
UR - https://www.deepdyve.com/lp/pubmed/individualised-treatment-targets-for-elderly-patients-with-type-2-32WTFeVm90
SP - 409
EP - 416
VL - 382
IS - 9890
DP - DeepDyve
ER -